Cargando…
Nanotechnology and pancreatic cancer management: State of the art and further perspectives
Pancreatic ductal adenocarcinoma (PDAC) represents a leading cause of cancer death and is often diagnosticated too late to allow adequate treatments. Lots of biomarkers have been discovered in lasts years but, to date, there is a lack of low-cost and non-invasive tools for PDAC early detection. None...
Autores principales: | Caputo, Damiano, Pozzi, Daniela, Farolfi, Tommaso, Passa, Roberto, Coppola, Roberto, Caracciolo, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040067/ https://www.ncbi.nlm.nih.gov/pubmed/33889275 http://dx.doi.org/10.4251/wjgo.v13.i4.231 |
Ejemplares similares
-
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022) -
Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection
por: Caputo, Damiano, et al.
Publicado: (2022) -
Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection
por: Caputo, Damiano, et al.
Publicado: (2023) -
Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test
por: Digiacomo, Luca, et al.
Publicado: (2023) -
Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
por: Palchetti, Sara, et al.
Publicado: (2019)